3 | SEC Filings Hub

Filing metadata

Accession number: 0001567619-22-008866
Form type: Form 3
Filer: Enliven Therapeutics, Inc.
CIK: CIK 1672619
Filed: Apr 25, 2022
Reporting period: Apr 21, 2022
Description: Initial ownership

Documents

0001567619-22-008866-index.htm

Complete submission

0001567619-22-008866.txt

directory listing

Filed by

Enliven Therapeutics, Inc.